{{Drugbox
| IUPAC_name    = 2-(3-Fluorophenyl)-3-methylmorpholine
| image         = 3-Fluorophenmetrazine.svg

<!--Clinical data-->
| tradename                =
| synonyms = 3-FPM, 3-FPH, PAL-593
| routes_of_administration =
| legal_UK = PSA
| legal_status = Illegal in Sweden and Switzerland

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|cas}}
| CAS_number = 1350768-28-3
| CAS_number2 = 1803562-83-5
| index_label =
| index2_label = HCl
| ATC_prefix =
| ATC_suffix =
| PubChem = 54673723
| PubChem2 = 75481405
| ChemSpiderID = 37509994
| ChemSpiderID2 = 34212559
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = BEV6RF569G

<!--Chemical data-->
| C=11 | H=14 | N=1 | O=1 | F=1
| smiles = CC1C(OCCN1)C2=CC(=CC=C2)F
| smiles2 = CC1C(OCCN1)C2=CC(=CC=C2)F.Cl
| StdInChI = 1S/C11H14FNO/c1-8-11(14-6-5-13-8)9-3-2-4-10(12)7-9/h2-4,7-8,11,13H,5-6H2,1H3
| StdInChI2 = 1S/C11H14FNO.ClH/c1-8-11(14-6-5-13-8)9-3-2-4-10(12)7-9;/h2-4,7-8,11,13H,5-6H2,1H3;1H
| StdInChIKey = VHYVKJAQSJCYCK-UHFFFAOYSA-N
| StdInChIKey2 = MHJBXKFJWSBWRE-UHFFFAOYSA-N
}}

'''3-Fluorophenmetrazine ''' (also known as '''3-FPM''', '''3-FPH''' and '''PAL-593''') is a [[Substituted phenylmorpholine|phenylmorpholine]]-based [[stimulant]] and [[Organofluorine chemistry|fluorinated]] [[Structural analog|analogue]] of [[phenmetrazine]] that has been sold online as a [[designer drug]].<ref>{{cite journal|first1=Gavin|last1=McLaughlin|first2=Noreen|last2=Morris|first3=Pierce V.|last3=Kavanagh|first4=Geraldine|last4=Dowling|title=Test purchase, synthesis and characterization of 3-fluorophenmetrazine (3-FPM) and differentiation from its ''ortho''- and ''para''-substituted isomers|url=http://onlinelibrary.wiley.com/doi/10.1002/dta.1945/abstract|journal=Drug Testing and Analysis|date=26 January 2016|issn=1942-7611|pages=|doi=10.1002/dta.1945|pmid=26810957|first5=John D.|last5=Power|first6=Brendan|last6=Twamley|first7=John|last7=O'Brien|first8=Brian|last8=Talbot|first9=Harald H.|last9=Sitte|first10=Simon D.|last10=Brandt}}</ref><ref>{{cite journal|first1=Matilda|last1=Bäckberg|first2=Jenny|last2=Westerbergh|first3=Olof|last3=Beck|first4=Anders|last4=Helander|title=Adverse events related to the new psychoactive substance 3-fluorophenmetrazine – results from the Swedish STRIDA project|url=http://www.tandfonline.com/doi/full/10.1080/15563650.2016.1211288|journal=Clinical Toxicology|date=5 August 2016|issn=1556-3650|pages=819–825|volume=54|issue=|doi=10.1080/15563650.2016.1211288|pmid=27491700}}</ref>

==Pharmacology==

3-FPM acts as a [[norepinephrine-dopamine releasing agent]] with EC<sub>50</sub> values of 43 nM and 30 nM, respectively.<ref name=patent>{{cite web | url=https://www.google.com/patents/US20130203752 | title=US Patent 20130203752 A1 – Phenylmorpholines and analogues thereof | date=8 August 2013 | author1=Bruce E. Blough | author2=Richard Rothman | author3=Antonio Landavazo | author4=Kevin M. Page | author5=Ann Marie Decker}}</ref> It shows only negligible efficacy as a releaser of serotonin, with an EC<sub>50</sub> value of 2558 nM.<ref name=patent />

Evaluation of its [[metabolic pathway]] revealed ''N''‐oxidation, aryl hydroxylation and subsequent ''O''‐methylation, alkyl hydroxylation, oxidation, and degradation of the ethyl‐bridge yielding the ''O/N''‐bis‐dealkylated metabolite, combinations thereof and further glucuronidation or sulfations.<ref>{{cite journal|first1=Marie|last1=Mardal|first2=Bram|last2=Miserez|first3=Richard|last3=Bade|first4=Tania|last4=Portolés|title=3-Fluorophenmetrazine, a fluorinated analogue of phenmetrazine: Studies on ''in vivo'' metabolism in rat and human, ''in vitro'' metabolism in human CYP isoenzymes and microbial biotransformation in ''Pseudomonas Putida'' and wastewater using GC and LC coupled to (HR)-MS techniques|url=http://www.sciencedirect.com/science/article/pii/S0731708516303284|journal=Journal of Pharmaceutical and Biomedical Analysis|date=5 September 2016|pages=485–495|volume=128|via=ScienceDirect|doi=10.1016/j.jpba.2016.06.011|pmid=27372653|first5=Markus|last5=Bischoff|first6=Félix|last6=Hernández|first7=Markus R.|last7=Meyer}}</ref>

==Legality==
Sweden's public health agency suggested to classify 3-Fluorophenmetrazine as illegal narcotic on June 1, 2015.<ref>{{cite web | url=https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2015/juni/23-nya-amnen-kan-klassas-som-narkotika-eller-halsofarlig-vara/ | title=23 nya ämnen kan klassas som narkotika eller hälsofarlig vara | publisher=Folkhälsomyndigheten | language=sv | date=1 June 2015 }}</ref> It was finally classified on October 15, 2015.<ref>{{cite web |url=https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2015/augusti/nya-substanser-klassas-som-narkotika-eller-halsofarlig-vara/ | title=Nya substanser klassas som narkotika eller hälsofarlig vara | publisher=Folkhälsomyndigheten | language=sv | date=18 August 2015 }}</ref>

3-Fluorophenmetrazine is illegal in Switzerland as of December 2015.<ref>{{cite web | url=https://www.admin.ch/opc/de/classified-compilation/20101220/index.html | title=Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien | publisher=Der Bundesrat | language=de}}</ref>

== See also ==
* [[Phenmetrazine]]
* [[Phendimetrazine]]
* [[2-Phenyl-3,6-dimethylmorpholine|6'-Methylphenmetrazine]]
* [[G-130]]
* [[Substituted phenylmorpholine|List of substituted phenylmorpholines]]

== References ==
{{reflist|35em}}

{{Stimulants}}

{{DEFAULTSORT:Fluorophenmetrazine, 3-}}
[[Category:Morpholines]]
[[Category:Norepinephrine-dopamine releasing agents]]
[[Category:Stimulants]]
[[Category:Designer drugs]]
[[Category:Fluoroarenes]]


{{nervous-system-drug-stub}}